Version 1
: Received: 17 April 2024 / Approved: 18 April 2024 / Online: 18 April 2024 (09:13:53 CEST)
How to cite:
Sen'kova, A.V.; Bishani, A.; Savin, I.A.; Zenkova, M.A.; Chernolovskaya, E.L. Effect of Immunostimulatory RNA on the Fibrosis Development in Bleomycin- or LPS-Induced Mouse Models. Preprints2024, 2024041228. https://doi.org/10.20944/preprints202404.1228.v1
Sen'kova, A.V.; Bishani, A.; Savin, I.A.; Zenkova, M.A.; Chernolovskaya, E.L. Effect of Immunostimulatory RNA on the Fibrosis Development in Bleomycin- or LPS-Induced Mouse Models. Preprints 2024, 2024041228. https://doi.org/10.20944/preprints202404.1228.v1
Sen'kova, A.V.; Bishani, A.; Savin, I.A.; Zenkova, M.A.; Chernolovskaya, E.L. Effect of Immunostimulatory RNA on the Fibrosis Development in Bleomycin- or LPS-Induced Mouse Models. Preprints2024, 2024041228. https://doi.org/10.20944/preprints202404.1228.v1
APA Style
Sen'kova, A.V., Bishani, A., Savin, I.A., Zenkova, M.A., & Chernolovskaya, E.L. (2024). Effect of Immunostimulatory RNA on the Fibrosis Development in Bleomycin- or LPS-Induced Mouse Models. Preprints. https://doi.org/10.20944/preprints202404.1228.v1
Chicago/Turabian Style
Sen'kova, A.V., Marina A. Zenkova and Elena L. Chernolovskaya. 2024 "Effect of Immunostimulatory RNA on the Fibrosis Development in Bleomycin- or LPS-Induced Mouse Models" Preprints. https://doi.org/10.20944/preprints202404.1228.v1
Abstract
Previously, we described a 19-base pair double-stranded RNA with 3'-trinucleotide overhangs, acting as immunostimulatory RNA (isRNA). This molecule demonstrated notable antiproliferative effects on cancer cells, inhibited tumor growth, and elicited immunostimulatory and antiviral responses by inducing cytokine and interferon production. Within this study, we compared the efficiency of lung fibrosis development, initiated in mice by BLM or LPS using different schemes of induction. Then we compared the effect of isRNA used in a preventive or therapeutic regimen on the development of fibrosis in selected BLM- and LPS-induced mouse models and showed that isRNA can be used in pathological conditions accompanied by the development of inflammation and the risk of fibrosis formation, without adverse side effects. Prophylactic regimen of isRNA application is beneficial for prevention of the development of pulmonary fibrosis.
Biology and Life Sciences, Biochemistry and Molecular Biology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
